Stay updated on Clinical Trial: INO-3112 & Durvalumab for HPV Cancers

Sign up to get notified when there's something new on the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T14:54:55.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T14:41:13.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1. The study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:47:09.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record details. The header and footer remain, but the main content is inaccessible due to the error.
    Difference
    21%
    Check dated 2026-09-19T19:33:13.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision tag on the page was updated from v3.6.5 to v3.6.6, indicating a new page version. The change does not modify study details or content visible to users.
    Difference
    0.0%
    Check dated 2026-08-29T20:17:42.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a new version is in effect. This change does not modify the displayed study data or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-08-08T23:29:47.000Z thumbnail image

Stay in the know with updates to Clinical Trial: INO-3112 & Durvalumab for HPV Cancers

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page.